S. Harpreet Dhaliwal's most recent trade in Vaxcyte Inc was a trade of 53,409 Common Stock done . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxcyte Inc | Harpreet S. Dhaliwal | Chief Technical Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 53,409 | 77,337 | - | 0 | Common Stock | |
| Vaxcyte Inc | Harpreet S. Dhaliwal | Chief Technical Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 46,424 | 46,424 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Harpreet S. Dhaliwal | Chief Technical Ops Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.98 per share. | 26 Feb 2026 | 465 | 76,580 | - | 62.0 | 28,821 | Common Stock |
| Vaxcyte Inc | Harpreet S. Dhaliwal | Chief Technical Ops Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.98 per share. | 26 Feb 2026 | 292 | 77,045 | - | 62.0 | 18,098 | Common Stock |
| Vaxcyte Inc | S. Harpreet Dhaliwal | Chief Technical Ops Officer | Sale of securities on an exchange or to another person at price $ 46.69 per share. | 31 Dec 2025 | 9,743 | 23,928 | - | 46.7 | 454,891 | Common Stock |
| Vaxcyte Inc | Harpreet S. Dhaliwal | Chief Technical Ops Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.41 per share. | 08 Sep 2025 | 1,204 | 33,670 | - | 32.4 | 39,022 | Common Stock |
| Vaxcyte Inc | Harpreet S. Dhaliwal | Chief Technical Ops Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.56 per share. | 02 Sep 2025 | 783 | 35,338 | - | 31.6 | 24,711 | Common Stock |
| Vaxcyte Inc | Harpreet S. Dhaliwal | Chief Technical Ops Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.56 per share. | 02 Sep 2025 | 464 | 34,874 | - | 31.6 | 14,644 | Common Stock |
| Vaxcyte Inc | Harpreet S. Dhaliwal | Chief Technical Ops Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.56 per share. | 02 Sep 2025 | 291 | 36,121 | - | 31.6 | 9,184 | Common Stock |
| Vaxcyte Inc | Harpreet S. Dhaliwal | SVP Cml Mfg & Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Harpreet S. Dhaliwal | SVP Cml Mfg & Supply Chain | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Dec 2022 | 3,990 | 96,010 | - | - | Stock Option (Right to Buy) | |
| Vaxcyte Inc | Harpreet S. Dhaliwal | SVP Cml Mfg & Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.06 per share. | 28 Dec 2022 | 3,990 | 21,808 | - | 25.1 | 99,989 | Common Stock |
| Vaxcyte Inc | Harpreet S. Dhaliwal | SVP Cml Mfg & Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.38 per share. | 02 Sep 2022 | 1,513 | 16,890 | - | 26.4 | 39,913 | Common Stock |